Mossoba Magdi M, Azizian Hormoz, Fardin-Kia Ali Reza, Karunathilaka Sanjeewa R, Kramer John K G
Food and Drug Administration, Center for Food Safety and Applied Nutrition, Office of Regulatory Science, College Park, MD, USA.
NIR Technologies Inc., Oakville, ON, L6M 2M2, Canada.
Lipids. 2017 May;52(5):443-455. doi: 10.1007/s11745-017-4250-5. Epub 2017 Apr 11.
Economically motivated adulteration (EMA) of extra virgin olive oils (EVOO) has been a worldwide problem and a concern for government regulators for a long time. The US Food and Drug Administration (FDA) is mandated to protect the US public against intentional adulteration of foods and has jurisdiction over deceptive label declarations. To detect EMA of olive oil and address food safety vulnerabilities, we used a previously developed rapid screening methodology to authenticate EVOO. For the first time, a recently developed FT-NIR spectroscopic methodology in conjunction with partial least squares analysis was applied to commercial products labeled EVOO purchased in College Park, MD, USA to rapidly predict whether they are authentic, potentially mixed with refined olive oil (RO) or other vegetable oil(s), or are of lower quality. Of the 88 commercial products labeled EVOO that were assessed according to published specified ranges, 33 (37.5%) satisfied the three published FT-NIR requirements identified for authentic EVOO products which included the purity test. This test was based on limits established for the contents of three potential adulterants, oils high in linoleic acid (OH-LNA), oils high in oleic acid (OH-OLA), palm olein (PO), and/or RO. The remaining 55 samples (62.5%) did not meet one or more of the criteria established for authentic EVOO. The breakdown of the 55 products was EVOO potentially mixed with OH-LNA (25.5%), OH-OLA (10.9%), PO (5.4%), RO (25.5%), or a combination of any of these four (32.7%). If assessments had been based strictly on whether the fatty acid composition was within the established ranges set by the International Olive Council (IOC), less than 10% would have been identified as non-EVOO. These findings are significant not only because they were consistent with previously published data based on the results of two sensory panels that were accredited by IOC but more importantly each measurement/analysis was accomplished in less than 5 min.
特级初榨橄榄油(EVOO)受经济利益驱动的掺假行为(EMA)一直是个全球性问题,长期以来受到政府监管机构的关注。美国食品药品监督管理局(FDA)的职责是保护美国公众免受食品故意掺假行为的侵害,并对具有欺骗性的标签声明拥有管辖权。为了检测橄榄油的EMA并解决食品安全漏洞,我们使用了先前开发的快速筛查方法来鉴定EVOO。首次将最近开发的傅里叶变换近红外光谱法(FT-NIR)与偏最小二乘法分析相结合,应用于在美国马里兰州大学公园市购买的标有EVOO的商业产品,以快速预测它们是否纯正、是否可能与精炼橄榄油(RO)或其他植物油混合,或者质量是否较低。在根据已公布的特定范围评估的88种标有EVOO的商业产品中,有33种(37.5%)满足了已公布的针对纯正EVOO产品确定的三项FT-NIR要求,其中包括纯度测试。该测试基于为三种潜在掺假物(高亚油酸油(OH-LNA)、高油酸油(OH-OLA)、棕榈油精(PO)和/或RO)的含量设定的限值。其余55个样品(62.5%)未满足为纯正EVOO确定的一项或多项标准。这55种产品的分类情况为:可能与OH-LNA混合的EVOO(25.5%)、OH-OLA(10.9%)、PO(5.4%)、RO(25.5%)或这四种中的任何一种组合(32.7%)。如果评估严格基于脂肪酸组成是否在国际橄榄理事会(IOC)设定的既定范围内,那么被认定为非EVOO的产品将不到10%。这些发现意义重大,不仅因为它们与先前基于两个获得IOC认可的感官小组的结果发表的数据一致,更重要的是每次测量/分析都在不到5分钟内完成。